{
  "docId": "019de071-473e-712d-87f0-b99471a2308d",
  "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea",
  "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7827299,
  "pageNumber": 4,
  "pageCount": 40,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide combines a funding timeline on the left with a strategic summary on the right.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/4",
  "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d",
  "deckJsonHref": "/decks/019de071-473e-712d-87f0-b99471a2308d.json",
  "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.32,
        "y": 0.12
      },
      "kind": "list",
      "text": "Chemistry at the core: Translate deep expertise in structure-based drug design into a novel portfolio of precisely targeted therapies.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0dec033d-1602-44a0-96b5-20de42cac27d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.22,
        "x": 0.04,
        "y": 0.22
      },
      "kind": "list",
      "text": "JUNE 2018 - FEB 2021 $50M Series A with DEERFIELD; APRIL 2021 $135M Series B led by BainCapital LIFE SCIENCES with additional participation from Fidelity, Wellington, Viking, etc.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46a1d7ce-76f1-4073-a251-6e0b1d6f5110",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.32,
        "y": 0.38
      },
      "kind": "list",
      "text": "Built for Patients: Mission to address medical needs for patients with cancer harboring resistance mutations in driver kinases.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a38a1b9-c5e3-4dce-a794-9506fa34e168",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.6,
        "x": 0.32,
        "y": 0.62
      },
      "kind": "list",
      "text": "Driven by Purpose: Parallel lead programs (NVL-520, NVL-655), multiple early discovery programs, and two product candidates identified in two years.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a04d2d6c-29ee-4880-a8ec-29964ad3ac7c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.15,
        "x": 0.08,
        "y": 0.12
      },
      "kind": "title",
      "text": "Nuvalent",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06985d27-4b47-4687-837f-d7bf4c26bcec",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}